A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

David B. Zhen, MD, discusses the results of the phase 3 CheckMate 649 trial in patients with advanced gastric cancer, ...

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

Optiscan completes first gastrointestinal (GI) flexible prototype to collect images from the GI tract and activates GI study ...

Unhealthy dietary habits, including processed foods, high salt intake, and sugary drinks, are fueling the rise of stomach and ...

Key opinion leaders explores the management of gastrointestinal side effects in patients on osimertinib, focusing on ...

Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...

St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Key opinion leaders discusses strategies for handling gastrointestinal side effects in patients taking osimertinib, including ...

Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified ...